Patents by Inventor Maurizio Zenoni

Maurizio Zenoni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060281916
    Abstract: The invention relates to a method for obtaining cefotetan acid substantially free of tautomer, by treating crude cefotetan with Al3+ ions which cause the tautomer to precipitate. The precipitate is eliminated by filtration to provide a solution from which practically tautomer-free cefotetan is obtained.
    Type: Application
    Filed: May 12, 2006
    Publication date: December 14, 2006
    Applicant: ACS DOBFAR S.p.A.
    Inventors: Maurizio ZENONI, Antonio MANCA, Riccardo MONGUZZI
  • Publication number: 20060258636
    Abstract: Crystalline Solvate of cefuroxime acid, useful for preparing the antibiotic cefuroxime sodium salt.
    Type: Application
    Filed: April 18, 2006
    Publication date: November 16, 2006
    Applicant: ACS DOBFAR S.p.A.
    Inventors: Maurizio ZENONI, Angelo Cattaneo
  • Patent number: 7129350
    Abstract: A process for the preparation of 3-cyclic-ether-substituted cephalosporins of formula I wherein the group CO2R1 is a carboxylic acid or a carboxylate salt and R2 has the formula: wherein A1 and A2 have the meanings given in the specification by reacting compound of formula II: wherein R2 is as defined above and R3 is para-nitrobenzyl or allyl with a compound R2 L wherein R2 is as defined above; and L is di-(C1-6 alkyl)phosphorothioate in the presence of a solvent and a base.
    Type: Grant
    Filed: February 11, 2004
    Date of Patent: October 31, 2006
    Assignee: Pfizer, Inc.
    Inventors: Juan C. Colberg, Maurizio Zenoni, Giovanni Fogliato, Alessandro Donadelli
  • Patent number: 7071329
    Abstract: Cephalosporins may be conveniently prepared by a process in which a benzathinium salt of formula (V) wherein: Z is benzathine; and X and R2 are as defined in the specification, is reacted with thiourea. The resulting product may be crystallized as a sodium salt, as an internal salt, or as a pharmaceutically acceptable salt.
    Type: Grant
    Filed: August 12, 2004
    Date of Patent: July 4, 2006
    Assignee: ACS Dobfar S.p.A.
    Inventors: Riccardo Monguzzi, Antonio Manca, Leonardo Marsili, Maurizio Zenoni
  • Publication number: 20060121119
    Abstract: A process for producing nanoparticles of paclitaxel and albumin having antitumor properties, by which a mixture obtained by adding paclitaxel in powder form to an aqueous solution of albumin with chloroform is subjected to high pressure homogenization treatment.
    Type: Application
    Filed: January 17, 2006
    Publication date: June 8, 2006
    Applicant: American Bioscience Inc.
    Inventors: Maurizio Zenoni, Simone Maschio
  • Publication number: 20060100424
    Abstract: Process for producing Cefepime, Cefpirome and Cefquinome, whereby a cephalosporin containing a quaternary ammonium group is reacted with thiourea to provide the aforesaid cephalosporins.
    Type: Application
    Filed: September 9, 2005
    Publication date: May 11, 2006
    Applicant: ACS DOBFAR S.p.A.
    Inventors: Antonio Manca, Riccardo Monguzzi, Maurizio Zenoni, Leonardo Marsili
  • Publication number: 20050119478
    Abstract: Cephalosporins may be conveniently prepared by a process in which a benzathinium salt of formula (V) wherein: Z is benzathine; and X and R2 are as defined in the specification, is reacted with thiourea. The resulting product may be crystallized as a sodium salt, as an internal salt, or as a pharmaceutically acceptable salt.
    Type: Application
    Filed: August 12, 2004
    Publication date: June 2, 2005
    Applicant: ACS DOBFAR S.p.A.
    Inventors: Riccardo Monguzzi, Antonio Manca, Leonardo Marsili, Maurizio Zenoni
  • Publication number: 20050119244
    Abstract: Cephalosporins may be conveniently prepared by a process in which 7-ACA is silylated, acylated, desilylated and then salified to give an intermediate which is eventually cyclized with thiourea.
    Type: Application
    Filed: April 12, 2004
    Publication date: June 2, 2005
    Applicant: ACS DOBFAR S.p.A.
    Inventors: Riccardo Monguzzi, Antonio Manca, Leonardo Marsili, Maurizio Zenoni
  • Publication number: 20050009747
    Abstract: The invention discloses highly purified daptomycin and to pharmaceutical compositions comprising this compound. The invention discloses a method of purifying daptomycin comprising the sequential steps of anion exchange chromatography, hydrophobic interaction chromatography and anion exchange chromatography. The invention also discloses a method of purifying daptomycin by modified buffer enhanced anion exchange chromatography. The invention also discloses an improved method for producing daptomycin by fermentation of Streptomyces roseosporus. The invention also discloses high pressure liquid chromatography methods for analysis of daptomycin purity. The invention also discloses lipopeptide micelles and methods of making the micelles. The invention also discloses methods of using lipopeptide micelles for purifying lipopeptide antibiotics, such as daptomycin. The invention also discloses using lipopeptide micelles therapeutically.
    Type: Application
    Filed: December 29, 2003
    Publication date: January 13, 2005
    Inventors: Thomas Kelleher, Jan-Ji Lai, Joseph DeCourcey, Paul Lynch, Maurizio Zenoni, Auro Tagliani
  • Publication number: 20040267008
    Abstract: This invention relates a process for preparing a compound of formula (I) 1
    Type: Application
    Filed: February 17, 2004
    Publication date: December 30, 2004
    Applicant: Pfizer Inc
    Inventors: Juan C. Colberg, John L. Tucker, Maurizio Zenoni, Giovanni Fogliato, Alessandro Donadelli, Isao Nagakura, Hiromasa Morita, Hideyuki Matsuo
  • Patent number: 6696412
    Abstract: The invention discloses highly purified daptomycin and to pharmaceutical compositions comprising this compound. The invention discloses a method of purifying daptomycin comprising the sequential steps of anion exchange chromatography, hydrophobic interaction chromatography and anion exchange chromatography. The invention also discloses a method of purifying daptomycin by modified buffer enhanced anion exchange chromatography. The invention also discloses an improved method for producing daptomycin by fermentation of Streptomyces roseosporus. The invention also discloses high pressure liquid chromatography methods for analysis of daptomycin purity. The invention also discloses lipopeptide micelles and methods of making the micelles. The invention also discloses methods of using lipopeptide micelles for purifying lipopeptide antibiotics, such as daptomycin. The invention also discloses using lipopeptide micelles therapeutically.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: February 24, 2004
    Assignee: Cubist Pharmaceuticals, Inc.
    Inventors: Thomas J. Kelleher, Jan-Ji Lai, Joseph P. DeCourcey, Paul Lynch, Maurizio Zenoni, Auro Tagliani
  • Publication number: 20040002601
    Abstract: A method for producing cephalosporins 7-substituted with an amino-thiazolylacetic group by reacting 7-ACA or its derivatives having the amino group and the carboxyl protected with reactive derivatives of amino-thiazolylacetic acid.
    Type: Application
    Filed: January 21, 2003
    Publication date: January 1, 2004
    Applicant: ACS DOBFAR S.p.A.
    Inventors: Maurizio Zenoni, Giovanni Fogliato, Mauro Filippi
  • Publication number: 20030187062
    Abstract: Antitumor formulation based on nanoparticles of paclitaxel and human serum albumin as obtained by the addition of a biocompatible acid to an aqueous albumin solution before this is mixed with paclitaxel during the nanoparticle production process, the injectable solutions of this formulation having a pH between 5.4 and 5.8 and having stability and inalterability with time.
    Type: Application
    Filed: March 10, 2003
    Publication date: October 2, 2003
    Applicant: ACS DOBFAR S.p.A.
    Inventors: Maurizio Zenoni, Simone Maschio
  • Publication number: 20030185894
    Abstract: A process for producing nanoparticles of paclitaxel and albumin having antitumor properties, by which a mixture obtained by adding paclitaxel in powder form to an aqueous solution of albumin with chloroform is subjected to high pressure homogenization treatment.
    Type: Application
    Filed: March 10, 2003
    Publication date: October 2, 2003
    Applicant: ACS DOBFAR S.p.A.
    Inventors: Maurizio Zenoni, Simone Maschio
  • Patent number: 6583291
    Abstract: A safe and economical process for obtaining salts of 4-carboxy-3-hydroxy-5-mercapto-isothiazole. This process comprises refluxing a disodium or dipotassium salt of 3-hydroxy-5-mercapto-4-isothiazole carbonitrile in an aqueous solution of sodium or potassium hydroxide to produce the desired salt. The desired salt may be precipitated out of solution by adjusting the pH downward to a minimum value of about pH 8. Compounds produced by this process may be used for producing semi-synthetic cephalosporins.
    Type: Grant
    Filed: April 17, 2002
    Date of Patent: June 24, 2003
    Assignee: ACS Dobfar S.p.A.
    Inventors: Maurizio Zenoni, Alessandro Donadelli, Marco Silvagni
  • Publication number: 20020198375
    Abstract: The process of the present invention and the preparation of the compound of the present invention are illustrated in the following reaction schemes. Except where otherwise indicated, in the reaction schemes and discussion that follow, substituents R1, R2, R3, L, A1, A2 and X are as defined above unless otherwise described.
    Type: Application
    Filed: December 4, 2001
    Publication date: December 26, 2002
    Applicant: Pfizer Inc.
    Inventors: Juan C. Colberg, Maurizio Zenoni, Giovanni Fogliato, Alessandro Donadelli
  • Publication number: 20020169327
    Abstract: A process for obtaining salts of 4-carboxy-3-hydroxy-5-mercapto-isothiazole which are compounds usable in the production of Cefotetan, and new compounds obtained thereby.
    Type: Application
    Filed: April 17, 2002
    Publication date: November 14, 2002
    Applicant: ACS DOBFAR S.p.A.
    Inventors: Maurizio Zenoni, Alessandro Donadelli, Marco Silvagni
  • Publication number: 20020099205
    Abstract: This invention relates a process for preparing a compound of formula (I) 1
    Type: Application
    Filed: December 4, 2001
    Publication date: July 25, 2002
    Applicant: Pfizer Inc.
    Inventors: Juan C. Colberg, John L. Tucker, Maurizio Zenoni, Giovanni Fogliato, Alessandro Donadelli
  • Publication number: 20020095034
    Abstract: An imipenem production process by which a compound of formula 1
    Type: Application
    Filed: December 31, 2001
    Publication date: July 18, 2002
    Applicant: ACS DOBFAR S.p.A.
    Inventors: Maurizio Zenoni, Manuel Camozzi, Simone Maschio
  • Patent number: 6255480
    Abstract: Aminothiazole derivatives having the carboxyl activated by means of thioesters, said derivatives being condensable with &bgr;-lactam nuclei to yield &bgr;-lactam antibiotics
    Type: Grant
    Filed: June 24, 1999
    Date of Patent: July 3, 2001
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: Maurizio Zenoni, Mario Leone, Maurizio Serra, Mauro Filippi